Using 3D imaging and computer models to allow fast computation, researchers developed a method they propose may be safer, more efficient and cost less than traditional wire-based fractional flow reserve (FFR) calculations for assessing coronary stenosis.

A force-sensing ablation treatment for paroxysmal atrial fibrillation (PAF) helped to improve outcomes in the SMART-AF study, according to results published Aug. 19 in the Journal of the American College of Cardiology. But an accompanying editorial raised questions.

Aspirin dosing patterns after MI seem to favor high doses, regardless of bleeding risks, according to a study published online Aug. 12 in Circulation: Cardiovascular Quality & Outcomes.

Framingham, Mass., August 4, 2014 – HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the appointment of Katrin Leadley, M.D., as Chief Medical Officer of HeartWare, effective September 1, 2014. 

The exceptions committee from the Commonwealth of Pennsylvania has announced its approval of the UPMC East application to perform elective PCI without onsite open heart surgery for their cardiac catheterization lab. The decision by the Commonwealth to provide the exception was based, in part, on UPMC East's successful application for accreditation by ACE.

Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.

Can atrial fibrillation (AF) or flutter during surgery predict stroke? Research published in the Aug. 13 issue of JAMA appears to confirm that it does.

Digoxin, for its wide use and history, may not be as safe for use in atrial fibrillation patients as it is assumed to be. Or is it? A study published Aug. 19 in the Journal of the American College of Cardiology attempted to answer this question.